Condition: Weight Regain · Weight Loss · Sponsor: Boston Scientific Corporation
The goal of this clinical trial is to evaluate weight loss with TORe and intensive lifestyle modification versus intensive lifestyle modification alone in subjects who have regained weight following a Roux-en-Y gastric bypass. Participants will randomized 2:1. Those randomized to the TORe arm will receive a TORe procedure and intensive lifestyle modification which consists of a well-balanced calorie restrictive diet, incorporation of exercise and coaching on lifestyle discussion. Participants randomized the lifestyle modification alone arm will be eligible to receive a TORe procedure at 6 months post enrollment. Total follow up will be 24 months.
This description comes directly from the study's public registry record.
Victoria Lazzari · 508-561-7296 · victoria.lazzari@bsci.com
Always discuss trial participation with your own doctor first.
| Hoag Memorial Hospital | Irvine, California, United States | Recruiting |
| Stanford University Medical Center | Stanford, California, United States | Not Yet Recruiting |
| Mayo Clinic | Jacksonville, Florida, United States | Recruiting |
| Orlando Health Inc | Orlando, Florida, United States | Recruiting |
| University of South Florida | Tampa, Florida, United States | Not Yet Recruiting |
| Rush University Medical Center | Chicago, Illinois, United States | Not Yet Recruiting |
| Mayo Clinic Foundation | Rochester, Minnesota, United States | Recruiting |
| NYU Grossman School of Medicine | New York, New York, United States | Not Yet Recruiting |
| University of Texas Houston Health Science Center | Houston, Texas, United States | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07015424